New Role for Anti-Doping Facility

Once the 2012 Olympics are over, the newly established drug testing lab will be turned into the world’s leading center for metabolic phenotyping.

By | August 2, 2012

wikimedia commons

The state-of-the-art Olympics antidoping laboratory, which opened last January in Essex, England, to analyze blood and urine samples from the thousands of incoming Olympic athletes, will be re-tooled as a center dedicated to metabolic phenotyping after the 2012 Games are finished this month. Originally funded by GlaxoSmithKline in partnership with King's College London, the center will pass on to the UK’s Medical Research Council (MRC) and the National Institute for Health Research (NIHR) at the close of the events.

"There is nothing like this anywhere in the world," Jeremy Nicholson, head of the surgery and cancer department at Imperial College London, who will become the center's first research director, told ScienceInsider

About 60 percent of the equipment in the center, including mass spectrometers, high performance liquid chromatographers, and gas chromatographers, will be used to analyze some 25,000 samples of blood, urine, and tissues in the first year of operation, ScienceInsider reported. Researchers will scour the samples for myriad molecules produced by the body's chemical reactions—known as the body’s “phenome”—and link them to disease.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  2. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  3. Opinion: On “The Impact Factor Fallacy”
  4. Unstructured Proteins Help Tardigrades Survive Desiccation
Business Birmingham